Literature DB >> 17414865

Most cases labeled as "retinal migraine" are not migraine.

Donna L Hill1, Robert B Daroff, Anne Ducros, Nancy J Newman, Valérie Biousse.   

Abstract

BACKGROUND: Monocular visual loss has often been labeled "retinal migraine." Yet there is reason to believe that many such cases do not meet the criteria set out by the International Headache Society (IHS), which defines "retinal migraine" as attacks of fully reversible monocular visual disturbance associated with migraine headache and a normal neuro-ophthalmic examination between attacks.
METHODS: We performed a literature search of articles mentioning "retinal migraine," "anterior visual pathway migraine," "monocular migraine," "ocular migraine," "retinal vasospasm," "transient monocular visual loss," and "retinal spreading depression" using Medline and older textbooks. We applied the IHS criteria for retinal migraine to all cases so labeled. To be included as definite retinal migraine, patients were required to have had at least two episodes of transient monocular visual loss associated with, or followed by, a headache with migrainous features.
RESULTS: Only 16 patients with transient monocular visual loss had clinical manifestations consistent with retinal migraine. Only 5 of these patients met the IHS criteria for definite retinal migraine. No patient with permanent visual loss met the IHS criteria for retinal migraine.
CONCLUSIONS: Definite retinal migraine, as defined by the IHS criteria, is an exceedingly rare cause of transient monocular visual loss. There are no convincing reports of permanent monocular visual loss associated with migraine. Most cases of transient monocular visual loss diagnosed as retinal migraine would more properly be diagnosed as "presumed retinal vasospasm."

Entities:  

Mesh:

Year:  2007        PMID: 17414865     DOI: 10.1097/WNO.0b013e3180335222

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  15 in total

1.  Reentrant spiral waves of spreading depression cause macular degeneration in hypoglycemic chicken retina.

Authors:  Yufei Yu; Laura M Santos; Linda A Mattiace; Manoel L Costa; Luciano C Ferreira; Kelly Benabou; Ana H Kim; John Abrahams; Michael V L Bennett; Renato Rozental
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  ICHD-3: what changes do we need regarding migraine?

Authors:  Gian Camillo Manzoni; Ilaria Grisendi; Paola Torelli
Journal:  Curr Pain Headache Rep       Date:  2011-06

3.  Response to: 'Cotton wool spots and migraine: a case series of three patients'.

Authors:  C R Svasti-Salee; T R W Nixon; B Muthusamy
Journal:  Eye (Lond)       Date:  2016-07-29       Impact factor: 3.775

Review 4.  Our evolving understanding of migraine with aura.

Authors:  Justin M DeLange; F Michael Cutrer
Journal:  Curr Pain Headache Rep       Date:  2014-10

5.  An Ocular Chameleon.

Authors:  Mohamed Shaffi; Nick Saad; Jennifer Arnold; Geoffrey Parker; Daniel Nguyen; Behzad Eftekhar
Journal:  Neurohospitalist       Date:  2022-06-24

Review 6.  Visual Phenomena Associated With Migraine and Their Differential Diagnosis.

Authors:  Ozan E Eren; Helmut Wilhelm; Christoph J Schankin; Andreas Straube
Journal:  Dtsch Arztebl Int       Date:  2021-10-01       Impact factor: 8.251

7.  Patterns of non-embolic transient monocular visual field loss.

Authors:  Axel Petzold; Niaz Islam; G T Plant
Journal:  J Neurol       Date:  2013-04-06       Impact factor: 4.849

8.  Optic neuritis presenting with amaurosis fugax.

Authors:  Amer M Awad; Bachir Estephan; Worthy Warnack; Olaf Stüve
Journal:  J Neurol       Date:  2009-09-02       Impact factor: 4.849

9.  The primary vascular dysregulation syndrome: implications for eye diseases.

Authors:  Josef Flammer; Katarzyna Konieczka; Andreas J Flammer
Journal:  EPMA J       Date:  2013-06-07       Impact factor: 6.543

Review 10.  Update on the evaluation of transient vision loss.

Authors:  John H Pula; Katherine Kwan; Carlen A Yuen; Jorge C Kattah
Journal:  Clin Ophthalmol       Date:  2016-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.